Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Inovio Pharmaceuticals, Inc. - Common Stock (NQ:INO)

1.130 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 21, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	580
Open	1.130
Bid (Size)	1.130 (4,400)
Ask (Size)	1.170 (200)
Prev. Close	1.130
Today's Range	1.130 - 1.130
52wk Range	1.030 - 2.979
Shares Outstanding	210,356,896
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers – INO

April 07, 2026

From Pomerantz LLP

Via GlobeNewswire

Inovio Deadline Today: Rosen Law Firm Urges Inovio Pharmaceuticals, Inc. (NASDAQ: INO) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

April 07, 2026

From The Rosen Law Firm, P.A.

Via Business Wire

Performance

YTD	-33.1%	-33.1%
1 Month	-29.8%	-29.8%
3 Month	-25.2%	-25.2%
6 Month	-51.5%	-51.5%
1 Year	-36.5%	-36.5%

More News

INO CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals Investors of Securities Class Action Deadline on April 7, 2026

April 07, 2026

From Faruqi & Faruqi, LLP

Via Business Wire

Bragar Eagel & Squire, P.C. Urgently Reminds Investors that a Class Action Lawsuit Has Been Filed Against Inovio Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm Before April 7th

April 06, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

On Monday, there are stocks with unusual volume. Let's take a look. ↗

April 06, 2026

Via Chartmill

Deadline Soon: Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

April 06, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm

April 06, 2026

From Schall Law

Via GlobeNewswire

Here are the top movers in Thursday's session. ↗

April 02, 2026

Via Chartmill

Top movers analysis in the middle of the day on 2026-04-02: top gainers and losers in today's session. ↗

April 02, 2026

Via Chartmill

What's Behind The Drop In Inovio Pharmaceuticals Stock Today? ↗

April 02, 2026

Via Benzinga

There are notable gap-ups and gap-downs in today's session. ↗

April 02, 2026

Via Chartmill

INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm

April 02, 2026

From Schall Law

Via GlobeNewswire

INO SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026

April 02, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

Discover the top movers in Thursday's pre-market session. ↗

April 02, 2026

Via Chartmill

Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers – INO

March 31, 2026

From Pomerantz LLP

Via GlobeNewswire

INOVIO DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Inovio Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 7 Deadline in Securities Class Action – INO

March 30, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm

March 30, 2026

From Schall Law

Via GlobeNewswire

INO DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important April 7 Deadline in Securities Class Action – INO

March 27, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Inovio Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

March 25, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc.and Certain Officers – INO

March 24, 2026

From Pomerantz LLP

Via GlobeNewswire

INO SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026

March 24, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm

March 23, 2026

From Schall Law

Via GlobeNewswire

Robbins LLP Reminds Inovio Pharmaceuticals, Inc. Stockholders of the Pending Class Action Against INO and Urges Harmed Stockholders to Seek More Information

March 20, 2026

From Robbins LLP

Via Business Wire

INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm

March 19, 2026

From Schall Law

Via GlobeNewswire

INO CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026

March 18, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

Frequently Asked Questions

Is Inovio Pharmaceuticals, Inc. - Common Stock publicly traded?

Yes, Inovio Pharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does Inovio Pharmaceuticals, Inc. - Common Stock trade on?

Inovio Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Inovio Pharmaceuticals, Inc. - Common Stock?

The ticker symbol for Inovio Pharmaceuticals, Inc. - Common Stock is INO on the Nasdaq Stock Market

What is the current price of Inovio Pharmaceuticals, Inc. - Common Stock?

The current price of Inovio Pharmaceuticals, Inc. - Common Stock is 1.130

When was Inovio Pharmaceuticals, Inc. - Common Stock last traded?

The last trade of Inovio Pharmaceuticals, Inc. - Common Stock was at 04/21/26 04:00 PM ET

What is the market capitalization of Inovio Pharmaceuticals, Inc. - Common Stock?

The market capitalization of Inovio Pharmaceuticals, Inc. - Common Stock is 237.70M

How many shares of Inovio Pharmaceuticals, Inc. - Common Stock are outstanding?

Inovio Pharmaceuticals, Inc. - Common Stock has 238M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.